| human | Q5 |
| P6178 | Dimensions author ID | 0776470311.06 |
| P496 | ORCID iD | 0000-0003-4336-7729 |
| P1153 | Scopus author ID | 7202088193 |
| P108 | employer | Imperial College London | Q189022 |
| Hammersmith Hospital | Q5645747 | ||
| Trinity College Dublin | Q258464 | ||
| P734 | family name | Rogers | Q16471355 |
| Rogers | Q16471355 | ||
| Rogers | Q16471355 | ||
| P735 | given name | Thomas | Q16428906 |
| Thomas | Q16428906 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q48348751 | A GAS-like gene family in the pathogenic fungus Candida glabrata |
| Q47659186 | A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study |
| Q44825501 | A comparison between amoxycillin/clavulanate and mezlocillin in abdominal surgical prophylaxis |
| Q47897423 | A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit |
| Q43721466 | A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients |
| Q33954369 | A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins |
| Q46971746 | A snapshot of genetic lineages of Mycobacterium tuberculosis in Ireland over a two-year period, 2010 and 2011. |
| Q43445446 | A trial of mezlocillin versus cefuroxime with or without metronidazole for the prevention of wound sepsis after biliary and gastrointestinal surgery |
| Q40797209 | An evaluation of empirical antibiotic therapy in febrile neutropenic patients |
| Q61905495 | An experience of diphtheria in Westminster |
| Q31040846 | Antifungal drug resistance: limited data, dramatic impact? |
| Q41121784 | Antifungal drug susceptibility testing. Working Party of the British Society for Antimicrobial chemotherapy |
| Q37866827 | Antifungal prophylaxis during treatment for haematological malignancies: are we there yet? |
| Q42054446 | Antigen detection in invasive aspergillosis |
| Q54209309 | CD3ε Expression Defines Functionally Distinct Subsets of Vδ1 T Cells in Patients With Human Immunodeficiency Virus Infection. |
| Q40949621 | Candida albicans stimulates IL-23 release by human dendritic cells and downstream IL-17 secretion by Vδ1 T cells. |
| Q56837329 | Candida glabrata STE12 is required for wild-type levels of virulence and nitrogen starvation induced filamentation |
| Q46659098 | Candida glabrata Ste11 is involved in adaptation to hypertonic stress, maintenance of wild-type levels of filamentation and plays a role in virulence. |
| Q47426451 | Candida glabrata Ste20 is involved in maintaining cell wall integrity and adaptation to hypertonic stress, and is required for wild-type levels of virulence. |
| Q40929951 | Characterization of Escherichia coli bloodstream isolates associated with mortality. |
| Q45286729 | Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies |
| Q42740321 | Community acquired pneumonia in elderly people. Current British guidelines need revision |
| Q61905439 | Community-acquired pneumonia |
| Q44626095 | Comparison of plasmid-mediated quinolone resistance and extended-spectrum β-lactamases in third-generation cephalosporin-resistant Enterobacteriaceae from four Irish hospitals. |
| Q42918830 | Comparison of two DNA microarrays for detection of plasmid-mediated antimicrobial resistance and virulence factor genes in clinical isolates of Enterobacteriaceae and non-Enterobacteriaceae |
| Q61905483 | Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation |
| Q40479969 | Deep-seated resistance in relapsed paratyphoid fever. |
| Q51027569 | Detailed characterization of the first high-level azithromycin-resistant Neisseria gonorrhoeae cases in Ireland. |
| Q37823011 | Detection and investigation of invasive mould disease |
| Q44078661 | Detection of antibodies to common antigens of pathogenic and commensal Neisseria species |
| Q61905426 | Detection of blaVIM-2 carbapenemase in Pseudomonas aeruginosa in Ireland |
| Q35639321 | Developments in the diagnostic mycology laboratory. |
| Q50222798 | Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips |
| Q44700391 | Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin |
| Q41765905 | Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in Ireland |
| Q33584660 | Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in New Zealand |
| Q40883658 | Draft Genome Sequences of Three Mycobacterium chimaera Respiratory Isolates. |
| Q54448634 | Dynamics of extracellular release of Aspergillus fumigatus DNA and galactomannan during growth in blood and serum. |
| Q44908635 | Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients |
| Q35947593 | Emergence of persistent Aspergillus terreus colonisation in a child with cystic fibrosis |
| Q36521332 | Enhanced Tracking of Nosocomial Transmission of Endemic Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Type IV Isolates among Patients and Environmental Sites by Use of Whole-Genome Sequencing. |
| Q41753239 | Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. |
| Q42337733 | Erratum for Abdolrasouli et al., Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing |
| Q42339230 | Erratum to: Surface layer proteins from virulent Clostridium difficile ribotypes exhibit signatures of positive selection with consequences for innate immune response |
| Q37925096 | European expert opinion on the management of invasive candidiasis in adults |
| Q38375318 | Evaluation of GenoType NTM-DR Assay for Identification of Mycobacterium chimaera |
| Q40166769 | Fourteen Draft Genome Sequences for the First Reported Cases of Azithromycin-Resistant Neisseria gonorrhoeae in Ireland. |
| Q61905445 | Fungal infections: a survey of laboratory services for diagnosis and treatment |
| Q35175339 | Gene expression profiles of human dendritic cells interacting with Aspergillus fumigatus in a bilayer model of the alveolar epithelium/endothelium interface |
| Q35676292 | Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing |
| Q54162651 | Glycopeptide Resistance in Gram-positive Bacteria. |
| Q38970329 | Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology |
| Q44582964 | Hospital-acquired Clostridium difficile diarrhoea and herd immunity |
| Q61905492 | INVESTIGATION OF INFECTION IN IMMUNOCOMPROMISED PATIENTS |
| Q39188817 | Identification of a novel mutation at the primary dimer interface of GyrA conferring fluoroquinolone resistance in Clostridium difficile. |
| Q40276070 | Identification of a novel sequence type of Escherichia coli as the causative agent of pyelonephritis and bloodstream infection |
| Q61905418 | Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study |
| Q61905489 | In-vitro activity of antifungal agents in combination with four quinolones |
| Q40763002 | Inactivation of transcription factor gene ACE2 in the fungal pathogen Candida glabrata results in hypervirulence |
| Q36905581 | Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime. |
| Q40267739 | Inter-country transfer of triazole-resistant Aspergillus fumigatus on plant bulbs |
| Q43752639 | Interactions in vitro between polyenes and imidazoles against yeasts |
| Q34575195 | Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country |
| Q42875146 | Is it time to stop using chloramphenicol on the eye? Fears are based on only six cases |
| Q41258327 | Isoprinosine does not influence the natural history of herpes zoster or postherpetic neuralgia |
| Q39394767 | Management of pulmonary aspergillosis in AIDS: an emerging clinical problem |
| Q35833250 | Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection. |
| Q41162621 | Molecular epidemiology of Mycobacterium abscessus complex isolates in Ireland. |
| Q47744200 | Molecular epidemiology of multi- and extensively-drug-resistant Mycobacterium tuberculosis in Ireland, 2001-2014. |
| Q54120197 | Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy. |
| Q36826645 | Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients. |
| Q41990206 | Neisseria meningitidis in a primary school |
| Q61905497 | Non-specific vaginitis: its diagnosis and treatment |
| Q33829717 | Nosocomial fungal infection: diagnosis and typing. |
| Q35067116 | Pathogen-specific DNA enrichment does not increase sensitivity of PCR for diagnosis of invasive aspergillosis in neutropenic patients |
| Q112296785 | Population genomics of the pathogenic yeast Candida tropicalis identifies hybrid isolates in environmental samples |
| Q38807467 | Possible Interplay Between Hospital and Community Transmission of a Novel Clostridium Difficile Sequence Type 295 Recognized by Next-Generation Sequencing. |
| Q52640341 | Post-influenzal triazole-resistant aspergillosis following allogeneic stem cell transplantation. |
| Q43864196 | Prevention of airborne fungal infection in immunocompromised patients |
| Q90984829 | Prevention of healthcare-associated invasive aspergillosis during hospital construction/renovation works |
| Q36922609 | Prevention of infection during neutropenia. |
| Q61905500 | Problems with cytomegalovirus in hospital practice |
| Q40756361 | Proteomic Profiling of Serological Responses to Aspergillus fumigatus Antigens in Patients with Invasive Aspergillosis |
| Q61585197 | Purification and characterization of a 93 kDa Aspergillus fumigatus antigen with diagnostic potential |
| Q35155803 | Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. |
| Q54328149 | RT-qPCR detection of Aspergillus fumigatus RNA in vitro and in a murine model of invasive aspergillosis utilizing the PAXgene® and Tempus™ RNA stabilization systems. |
| Q28603336 | Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study |
| Q54381304 | Real-time PCR and quantitative culture for monitoring of experimental Aspergillus fumigatus intracranial infection in neutropenic mice. |
| Q41909283 | Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regulated exopolysaccharide colanic acid. |
| Q40782120 | Response rates to a staged antibiotic regimen in febrile neutropenic patients |
| Q57919991 | Retrospective evaluation of a latex agglutination test for diagnosis of invasive aspergillosis in immunocompromised patients |
| Q96642114 | Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion |
| Q57927131 | Rhinocerebral mucormycosis following bone marrow transplantation |
| Q24647631 | Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence |
| Q34782378 | Spread of Clostridium difficile among patients receiving non-absorbable antibiotics for gut decontamination. |
| Q38177271 | Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design. |
| Q36320846 | Surface layer proteins from virulent Clostridium difficile ribotypes exhibit signatures of positive selection with consequences for innate immune response |
| Q42625518 | The Aspergillus fumigatus transcriptional activator CpcA contributes significantly to the virulence of this fungal pathogen |
| Q44813835 | The Aspergillus pH-responsive transcription factor PacC regulates virulence. |
| Q61905485 | The inhibitory effect of serum on the growth of Torulopsis glabrata |
| Q61905482 | The phenotypic relationship of Neisseria polysaccharea to commensal and pathogenic Neisseria spp |
| Q28476745 | The temporal dynamics of differential gene expression in Aspergillus fumigatus interacting with human immature dendritic cells in vitro |
| Q40763671 | Toxin Immunoassays and Clostridium difficile Infection |
| Q61905467 | Transmission of toxoplasmosis by bone marrow transplant associated with Campath-1G |
| Q54193070 | Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin. |
| Q37026471 | Treatment of zygomycosis: current and new options |
| Q38416384 | Tuberculosis incidence in the Irish Traveller population in Ireland from 2002 to 2013. |
| Q41503477 | Typhlocolitis associated with Clostridium difficile ribotypes 078 and 110 in neonatal piglets from a commercial Irish pig herd |
| Q57927002 | Value of antigen detection in predicting invasive pulmonary aspergillosis |
| Q28587032 | Virulence comparisons of Aspergillus nidulans mutants are confounded by the inflammatory response of p47phox-/- mice. |
| Q35227352 | Virus infections complicating bone marrow transplantation |
| Q35680209 | Voriconazole for serious fungal infections. |
| Q40984050 | Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections. |
Search more.